By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The David H. Murdock Research Institute today announced it has acquired the Immune Tolerance Institute for an undisclosed amount.

The acquisition enhances DHMRI's capabilities to discover novel immunomodulatory therapies and corresponding biomarkers for translation into clinical practice, DHMRI said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.